Safety and Efficacy of Varicella Zoster Immune Globulin (Human) VariZIG in Patients at Risk of Varicella Infection

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00338442
Recruitment Status : Approved for marketing
First Posted : June 20, 2006
Last Update Posted : April 4, 2013
Information provided by (Responsible Party):
Cangene Corporation

No Study Results Posted on for this Study
  Recruitment Status : Approved for marketing
  Estimated Primary Completion Date : December 2009
  Estimated Study Completion Date : December 2009